NTAGI meeting on vaccination for 5-12-year-olds inconclusive: Sources

 

India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained inconclusive on Wednesday, according to sources.

The NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no decision on whether to expand the program to this younger group was taken.

Last month the regulator had approved two vaccines--Serum Institute's Covovax and Biological E-made Corbevax--for use in 5-12-year-old children.

However the NTAGI decides on whether these would be used in India's Covid-19 vaccination programme.

Read Complete Article


Comments

Popular posts from this blog

I'm Tamilian first, says Sathyaraj post 'Baahubali 2' row

Twitter may soon allow users to add videos, pictures in same tweet: Report

Note ban distress leaves scant room for giveaways in Budget 2017